What's new

Human medicines European public assessment report (EPAR): Riulvy, tegomil fumarate, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR): Riulvy, tegomil fumarate, Status: Opinion under re-examination

May 23, 2025 - 12:15
 0
Human medicines European public assessment report (EPAR): Riulvy, tegomil fumarate, Status: Opinion under re-examination
Human medicines European public assessment report (EPAR): Riulvy, tegomil fumarate, Status: Opinion under re-examination
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Aucatzyl, obecabtagene...

Next Article

Human medicines European public assessment report (EPAR): Emtricitabine / Tenofo...

Related Posts

EU Implementation Guide (IG) on veterinary medicines pr...

May 21, 2025  0

Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 May 2025, 12:30 (CEST) to 22 May 2025, 17:30 (CEST)

Clinical Trials Information System (CTIS): Information ...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0